RT Journal Article
SR Electronic
T1 Highly predictive regression model of active cases of COVID-19 in a population by screening wastewater viral load
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.07.02.20144865
DO 10.1101/2020.07.02.20144865
A1 Vallejo, Juan A.
A1 Rumbo-Feal, Soraya
A1 Conde-Pérez, Kelly
A1 López-Oriona, Ángel
A1 Tarrío, Javier
A1 Reif, Rubén
A1 Ladra, Susana
A1 Rodiño-Janeiro, Bruno K.
A1 Nasser, Mohammed
A1 Cid, Ángeles
A1 Veiga, María C
A1 Acevedo, Antón
A1 Lamora, Carlos
A1 Bou, Germán
A1 Cao, Ricardo
A1 Poza, Margarita
YR 2020
UL http://medrxiv.org/content/early/2020/07/06/2020.07.02.20144865.abstract
AB The quantification of the SARS-CoV-2 load in wastewater has emerged as a useful method to monitor COVID-19 outbreaks in the community. This approach was implemented in the metropolitan area of A Coruña (NW Spain), where wastewater from the treatment plant of Bens was analyzed to track the epidemic’s dynamic in a population of 369,098 inhabitants. We developed statistical regression models that allowed us to estimate the number of infected people from the viral load detected in the wastewater with a reliability close to 90%. This is the first wastewater-based epidemiological model that could potentially be adapted to track the evolution of the COVID-19 epidemic anywhere in the world, monitoring both symptomatic and asymptomatic individuals. It can help to understand with a high degree of reliability the true magnitude of the epidemic in a place at any given time and can be used as an effective early warning tool for predicting outbreaks.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was funded by Project INV04020 from the University of A Coruna Foundation (FUAC-UDC) and EDAR Bens S.A., A Coruna, Spain, awarded to MP, by Projects PI15/00860 to GB and PI17/01482 to MP, all within in the National Plan for Scientific Research, Development and Technological Innovation 2013-2016 and funded by the ISCIII - General Subdirection of Assessment and Promotion of the Research-European Regional Development Fund (FEDER) A way of making Europe. The study was also funded by project IN607A 2016/22 (GAIN- Xunta de Galicia, Spain) awarded to GB. This work was also supported by Planes Nacionales de I+D+i 2008-2011/2013-2016 and Instituto de Salud Carlos III, Subdireccion General de Redes y Centros de Investigacion Cooperativa, Ministerio de Economia y Competitividad, Spanish Network for Research in Infectious Diseases (REIPI RD16/0016/006) co-financed by European Regional Development Fund A way to achieve Europe and operative program Intelligent Growth 2014-2020. The publication was also supported by the European Virus Archive Global (EVA-GLOBAL) project that has received funding from the Horizon 2020 European Union research and innovation program under grant agreement No 871029. SR-F was financially supported by REIPI RD16/0016/006, KC-P by IN607A 2016/22 and the Spanish Association against Cancer (AECC) and JAV by IN607A 2016/22. This research has been also supported by MINECO grant MTM2017-82724-R awarded to RC, and by the Xunta de Galicia (Grupos de Referencia Competitiva ED431C-2016-015, awarded to RC, ED431C 2017/58, awarded to SL, and Centro Singular de Investigacion de Galicia ED431G 2019/01, awarded to RC and SL, all of them through the ERDF, and ED431C 2017/66, awarded to MCV. The authors wish to acknowledge the NORMAN Collaboration in the time of Covid19 European network. Authors would like to give special thanks to the Board of Directors from EDAR Bens. Also, we would like to thank Fernanda Rodriguez from the Research Support Services (SAI) at the University of A Coruna, Laura Larriba, from SERGAS, who helped in samples and data collection in CHUAC, Francisco Perez, Javier Fernandez Romero and Cristina Rodriguez Freire from Cadaqua for their help in sample collection at WWTP Bens, Andres Paz-Ares and Xurxo Hervada, from SERGAS, who provided the anonymized patient database and Amalia Jacome, Ana Lopez-Cheda, Rebeca Pelaez and Wende Safari, from CITIC at UDC, who processed that database to produce the epidemiological series at the municipality level, and Fiona Veira McTiernan for editing. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Authors confirm that it was not necessary to certify the approval of the ethics committee to carry out this work.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe authors declare that all data supporting the findings of this study are available within the article and Supplementary Information files, and also are available from the corresponding authors on reasonable request.